Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis (Q33501814)

27 July 2017

1 reference

title

Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis (English)

1 reference

heparin-induced thrombocytopenia

27 July 2017

0 references

0 references

1 reference

1 reference

1 reference

Nelson-Piercy C

1

1 reference

27 July 2017

publication date

1 September 1997

1 reference

Bailliere's clinical obstetrics and gynaecology

27 July 2017

published in

1 reference

27 July 2017

volume

11

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

489-509

1 reference

Low 1,25-dihydroxyvitamin D in heparin-induced osteopenia

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Heparin-induced thrombocytopenia and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Pregnancy-associated osteoporosis: report of two cases with long-term bone density follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Enoxaparin. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Osteoporosis of pregnancy: long-term follow-up of patients and their offspring

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

1 reference

7 January 2021

Heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Osteopenia in pregnancy during long-term heparin treatment: a radiological study post partum

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Bone mineral density during long-term prophylaxis with heparin in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Calcium homeostasis in pregnancy during long-term heparin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Pregnancy associated osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Heparin augments osteoclast resorption-stimulating activity in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Transient osteoporosis of the hip in pregnancy: natural history of changes in bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Ultrasonographic bone characteristics during normal pregnancy: longitudinal and cross-sectional evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Idiopathic transient osteoporosis of the hip in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Thrombosis prophylaxis in obstetrics and gynaecology.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

1 reference

7 January 2021

Severe heparin osteoporosis in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Calcium homeostasis in pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Structural determinants of the capacity of heparin to inhibit collagen synthesis in 21-day fetal rat calvariae

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Pregnancy-associated osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Changes in bone density and biochemical markers of bone turnover in pregnancy-associated osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Low molecular weight heparin in prevention of perioperative thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Treatment of Patients With Antiphospholipid Antibodies During Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

No transplacental passage of standard heparin or an enzymatically depolymerized low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Long-term administration of heparin and heparin fractions and osteoporosis in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Low molecular weight heparin for obstetric thromboprophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Rush desensitization in heparin hypersensitivity: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Heparin-induced skin reaction due to two different preparations of low molecular weight heparin (LMWH)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Low-molecular-weight heparin in venous thrombosis during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Heparin-induced thrombocytopenia: cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Post-pregnancy osteoporosis associated with hypercalcaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Idiopathic osteoporosis during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Pregnancy-associated osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Placental transfer of glycosaminoglycans in the human perfused placental cotyledon model

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Placental transfer of low-molecular weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Thrombolytic therapy of pulmonary artery embolism in early pregnancy with recombinant tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Bone density studies in pregnant women receiving heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Congenital antithrombin III deficient neonate treated with antithrombin III concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Effects of acid and basic fibroblast growth factor and heparin on resorption of cultured fetal rat long bones

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Prolonged heparin therapy in pregnancy causes bone demineralization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Heparin-induced skin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Bone mineral density and bone histomorphometric assessments of postpregnancy osteoporosis: a report of five patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

Histomorphometric evaluation of reversible heparin-induced osteoporosis in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980024-7

7 January 2021

10.1016/S0950-3552(97)80024-7

Identifiers

DOI

1 reference

27 July 2017

1 reference